350
On 8/05/2008, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 542. The active ingredient is Ribonucleotide reductase R2 specific phosphorothioate oligonucleotide for treatment of acute myeloid leukaemia.